MiR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2897-2902

  Lei, Lin ^a   Huang, Yaping ^a   Gong, Wenrong ^b  

^a Xiangyang Central Hospital   (China)

^b HUBEI UNIVERSITY OF ARTS AND SCIENCE   (China)

Author keywords

Chemotherapy; Invasion; miR 205; Non small cell lung cancer

Indexed keywords

MICRORNA 205; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER RESISTANCE; CANCER TISSUE; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84892402188     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2755     Document Type: Article

References (25)

1. Travis WD, Brambilla E, Noguchi M, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: 244-285, 2011.
2. Jemal A, Ma J, Rosenberg PS, Siegel R and Anderson WF: Increasing lung cancer death rates among young women in southern and midwestern States. J Clin Oncol 30: 2739-2744, 2012.
3. Marshall E: Cancer research and the $90 billion metaphor. Science 331: 1540-1541, 2011.
4. Boeri M, Pastorino U and Sozzi G: Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J 18: 268-274, 2012.
5. Wu Y, Crawford M, Mao Y, et al: Therapeutic delivery of microRNA-29b by cationic lipoplexes for lung cancer. Mol Ther Nucleic Acids 2: e84, 2013.
6. Kesanakurti D, Maddirela DR, Chittivelu S, Rao JS and Chetty C: Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer. Biochem Biophys Res Commun 434: 627-633, 2013.
7. Miao LJ, Huang SF, Sun ZT, et al: MiR-449c targets c-Myc and inhibits NSCLC cell progression. FEBS Lett 587: 1359-1365, 2013.
8. Zhang H, Zhao M, Lv Z, et al: MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol Biochem 31: 56-65, 2013.
9. Liu J, Lu KH, Liu ZL, Sun M, De W and Wang ZX: MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer 12: 519, 2012.
10. Yang M, Shen H, Qiu C, et al: High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 49: 604-615, 2013.
11. Mallick R, Patnaik SK and Yendamuri S: MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis. J Carcinog 9: 2010. doi: 10.4103/1477-3163.67074.
12. Su N, Qiu H, Chen Y, Yang T, Yan Q and Wan X: miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. Oncol Rep 29: 2297-2302, 2013.
13. Xie H, Zhao Y, Caramuta S, Larsson C and Lui WO: miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One 7: e46990, 2012.
14. Du L and Pertsemlidis A: microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther 12: 1221-1239, 2012.
15. Nana-Sinkam SP and Croce CM: Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 93: 98-104, 2013.
16. Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A and Annilo T: Meta-analysis of microRNA expression in lung cancer. Int J Cancer 132: 2884-2893, 2013.
17. Wang D, Wang S, Liu Q, Wang M, Wang C and Yang H: SZ-685C exhibits potent anticancer activity in both radiosensitive and radioresistant NPC cells through the miR-205-PTEN-Akt pathway. Oncol Rep 29: 2341-2347, 2013.
18. Wu H, Zhu S and Mo YY: Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 19: 439-448, 2009.
19. Boll K, Reiche K, Kasack K, et al: MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32: 277-285, 2013.
20. Qin AY, Zhang XW, Liu L, et al: MiR-205 in cancer: an angel or a devil? Eur J Cell Biol 92: 54-60, 2013.
21. Yamada KM and Araki M: Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 114: 2375-2382, 2001.
22. Panagiotou I, Tsiambas E, Lazaris AC, et al: PTEN expression in non small cell lung carcinoma based on digitized image analysis. J BUON 17: 719-723, 2012.
23. Li G, Zhao J, Peng X, Liang J, Deng X and Chen Y: The mechanism involved in the loss of PTEN expression in NSCLC tumor cells. Biochem Biophys Res Commun 418: 547-552, 2012.
24. Qu C, Liang Z, Huang J, et al: MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 11: 785-796, 2012.
25. Karaayvaz M, Zhang C, Liang S, Shroyer KR and Ju J: Prognostic significance of miR-205 in endometrial cancer. PLoS One 7: e35158, 2012.